Zantac Claims

Ranitidine, sold mostly under the brand name Zantac, is a drug that relieves or treats heartburn, gastroesophageal reflux disease, acid indigestion, and gastric ulcers. In June 2019, the independent laboratory Valisure found NDMA, a carcinogenic substance, in the medication. The concentration of NDMA in Zantac was 500 times greater than the safe intake limit. As a consequence, people who took the medication for one year or longer have a significantly higher risk of developing cancer. It is important to note that Zantac 360, the drug manufactured by Sanofi, contains famotidine, which makes it safe to use. Still, if you took ranitidine made by another pharmaceutical company and came to struggle with cancer, we encourage you to contact our attorneys, as you may be entitled to compensation.

Claim Application

Over 15 million people took Zantac before the link between NDMA and cancer was discovered

In April 2022, there were 2,100 Zantac cancer lawsuits pending in federal court. However, the real number of these lawsuits is over 50,000.

The chemical nitrosodimethylamine, lurking in Zantac and other drugs with ranitidine as the active ingredient for nearly four decades, is a probable carcinogen.

While the medication already contains NDMA, when a person takes Zantac, their body produces even more of this dangerous chemical because of the instability of ranitidine. People who took Zantac and developed cancer file lawsuits because:

  • the drug is defective, as ranitidine is unstable and may cause serious damage to the body
  • the Zantac manufacturers failed to warn of the cancer risk associated with taking the drug

More than 160,000 consumers have filed claims in a U.S. federal registry. If only 60% of these people further pursue their claims, the settlement value may reach between $7.5 billion and $10 billion. The ranitidine manufacturers GlaxoSmithKline, Haleon, and Sanofi have already lost $40 billion of market value in a matter of days. Madison County, Illinois, is a venue where juries have given big verdicts in the past. Two residents of that state are suing over a dozen manufacturers, including:

  • GlaxoSmithKline
  • Pfizer
  • Boehringer Ingelheim
  • Sanofi

Over 1,700 cases are consolidated before a federal judge in Florida in a multi-district litigation. Soon, it will be decided whether they go to trial or are dismissed, which will be crucial for the defendants. Furthermore, many generic manufacturers have also been listed as defendants in Zantac cancer lawsuits, including Sun Pharmaceuticals, Doctor Reddy's, and Teva Pharmaceutical Industries Ltd. Nevertheless, the greatest exposure concerns the above defendants. While Sanofi claims that "the plaintiff will be unable to prove that Zantac causes any type of cancer," GlaxoSmithKline stated that the litigation was "inconsistent with the scientific consensus.

The diseases associated with Zantac use that make consumers eligible to seek compensation

Numerous medical specialists who diagnosed people with cancer after taking Zantac said they had no family history or genetic markers for the disease. Instead, doctors told patients their cancer was the result of exposure to something from their environment, which might include the NDMA in Zantac. The following are the cancer diagnoses that make a person eligible to file a claim with one or multiple ranitidine manufacturers:

Out of these malignant diseases, bladder cancer has the strongest causal relation with NDMA exposure. The symptoms of overexposure to NDMA include hepatitis, liver failure, jaundice, skin rashes, hair loss, nausea, fever, vomiting, abdominal cramps, and dizziness. Primary pulmonary hypertension and Chron's disease also have a link to Zantac use. Nonetheless, people cannot file a claim if they used the drug and developed these two health problems.

Eligibility criteria for people who intend to file a Zantac cancer claim

While each case is unique and must be thoroughly reviewed by a lawyer whose area of practice is defective drugs, consumers seeking legal recourse must meet certain requirements to become eligible for a Zantac cancer claim. These are the main eligibility criteria one must meet to qualify for compensation:

  • Zantac use: you must prove that you took Zantac for at least one year before receiving your cancer diagnosis by sending your prescriptions (if you were prescribed the drug) or receipts and a doctor's note (if you used over-the-counter ranitidine) to us
  • cancer diagnosis: you must have been diagnosed with one of the cancers that qualify you for filing a claim, and there must be less than 20 years between the last time you took Zantac and your first diagnosis
  • link between diagnosis and Zantac: you must have taken Zantac at least once a week for one year or longer, and if you took high doses, the connection between your cancer diagnosis and ranitidine use will be stronger, as the length of time you have taken Zantac also influences the case

Even if you are not sure whether you are eligible for compensation from the Zantac manufacturers, we advise you to contact our law firm anyway. We have the necessary experience, knowledge, and resources to determine whether you meet the criteria for filing a claim. Taking legal action will not only provide you with financial compensation that will cover the cost of your treatment but may also discourage manufacturers from being negligent in the future.

A timeline of events regarding Zantac

Our skilled attorneys will help you file your Zantac cancer claim

With over 25 years of experience in toxic exposure and defective drug cases, our skilled attorneys will provide you with quality legal assistance if you took Zantac or ranitidine by another manufacturer and developed cancer. Because we know how overwhelming and exhausting struggling with a malignant disease can be, we will do all in our power to make the legal process as easy to navigate as possible for you. Our legal team will guide you through every step of the process and keep you posted regarding the progress of your case. The only documents we will request are evidence of you having taken Zantac in the form of prescriptions or receipts and your medical records clearly stating your cancer diagnosis and its link to ranitidine use. After we carefully review your case, we will determine whether you qualify for filing a Zantac cancer claim. If you are eligible, we will start preparing your claim for submission, and you will eventually obtain the maximum compensation available for your diagnosis. Because we work on a contingency fee basis, you will not have to pay our law firm anything unless we recover money for you.